Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immune Therapeutics Inc (OTCQB:IMUN)

0.20
Delayed Data
As of Jul 31
 +0.065 / +48.15%
Today’s Change
0.05
Today|||52-Week Range
0.37
+17.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.001.6M2.9M2.9M
 
 
 
 
 
Operating ExpensesGross Income0.00-1.6M-2.9M-2.9M
 
 
 
 
General Expenses--27.7M93.1M30.7M
 
 
 
 
Research And Development0.005.0M22.0M7.5M
 
 
 
 
Total Operating Expenses0.0029.3M96.0M33.6M
 
 
 
 
 
Non-Operating ExpensesOperating Income0.00-29.3M-96.0M-33.6M
 
 
 
 
Extraordinary Charge0.00-145.9M-8.6M-15.9M
 
 
 
 
Interest Expense On Debt31.3K27.0K1.4M388.2K
 
 
 
 
 
Other Expenses0.000.00-224.00-783.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.3K-175.2M-106.1M-49.9M
 
 
 
 
 
Minority Interest0.000.000.00-1.7M
 
 
Discontinued Operations-94.4K231.4K0.000.00
 
 
 
Net Income-125.7K-175.0M-106.1M-48.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS113.6425.6M57.2M98.5M
 
 
 
 
 
Shares To Calculate EPS Diluted113.6425.6M57.2M98.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1,110.00-$6.84-$1.85-$0.49
 
 
 
 
 
EPS Diluted-$1,110.00-$6.84-$1.85-$0.49